J. Clarridge
Clinical Microbiology Reviews · 2004
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 15 researchers here, as inferred from the citation graph.
Whom J. Clarridge trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Clarridge overall
- S. Chakravorty
- D. O'sullivan
- B. Jasim
- Sujatha Srinivasan
- bullet C John
- Danica A Helb
- L. Giblin
- Noah G. Hoffman
- Hema Chandran
- Orna Mizrahi-Man
Papers from J. Clarridge's perspective
Ordered by how strongly the researchers J. Clarridge trusts endorse each paper. Same corpus, a different order for every researcher.
- Report of the ad hoc committee for the re-evaluation of the species definition in bacteriology. (International Journal of Systematic and Evolutionary Microbiology)
- 16S Ribosomal DNA Sequence Analysis of a Large Collection of Environmental and Clinical Unidentifiable Bacterial Isolates (Journal of Clinical Microbiology)
- Endocarditis Due to Rare and Fastidious Bacteria (Clinical Microbiology Reviews)
- What's in a name?
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro (Cell Discovery)
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (International Journal of Antimicrobial Agents)
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study (The Lancet)
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR (Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin)
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study (Lancet. Infectious Diseases (Print))
- Viral dynamics in mild and severe cases of COVID-19 (Lancet. Infectious Diseases (Print))